Atomwise is a San Francisco, CA-based company that develops artificial intelligence systems for drug discovery.

Atomwise uses artificial intelligence to help discover new medicines and agricultural compounds. Its groundbreaking AtomNet technology reasons like a human chemist, using powerful deep learning algorithms and supercomputers to analyze millions of potential molecules each day. 

Atomwise was founded in 2012 formerly known as Chematria, Inc. and changed its name to Atomwise, Inc. in 2015. The company is based in San Francisco, California.

Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions.

Atomwise has launched more than 50 discovery projects in partnership with the world’s top research companies and universities.



  • Year founded: 2012
  • Funding Info: $51.3M in 5 funding rounds (Last funding type: Series A)
  • Yearly Revenue: $5M-$10M (2017)
  • Employee Size: 11-50
  • Business Valuation: Unknown
  • City/Town: San Francisco
  • State: California
  • Country: United States
Related businesses